13124-11-3 Usage
Uses
Used in Pharmaceutical Industry:
4-(2,4-DICHLOROPHENYL)-3-THIOSEMICARBAZIDE is used as a potential therapeutic agent for its antifungal, antimicrobial, and anticancer properties. Its diverse biological activities make it a candidate for the development of new drugs to combat various diseases and infections.
Used in Research and Development:
In the field of scientific research, 4-(2,4-DICHLOROPHENYL)-3-THIOSEMICARBAZIDE serves as a subject for further investigation to understand its chemical behavior, potential interactions with biological systems, and possible applications in medicine and other industries. 4-(2,4-DICHLOROPHENYL)-3-THIOSEMICARBAZIDE's unique structure and properties may lead to the discovery of new compounds with enhanced therapeutic effects or other beneficial uses.
Check Digit Verification of cas no
The CAS Registry Mumber 13124-11-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,2 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13124-11:
(7*1)+(6*3)+(5*1)+(4*2)+(3*4)+(2*1)+(1*1)=53
53 % 10 = 3
So 13124-11-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H7Cl2N3S/c8-4-1-2-6(5(9)3-4)11-12-7(10)13/h1-3,11H,(H3,10,12,13)
13124-11-3Relevant articles and documents
Antiimplantation Agents: Part I - 1-Arylthiosemicarbazides
Nagarajan, K.,Talwalker, P.K.,Kulkarni, C.L.,Venkateswarlu, A.,Prabhu, S.S.,Nayak, G.V.
, p. 1243 - 1257 (2007/10/02)
Several 1-arylthiosemicarbazides, 2-arylhydrazinothiazolines and 2-arylhydrazinodihydrothiazines have been examined for their antiimplantation activity in rats.Among the active compounds, 4-methyl-1-(3,5-bistrifluoromethylphenyl)thiosemicarbazide (3, C 2696-Go) and the corresponding 4,4-dimethyl (47), ethyl (4), n-butyl (5) and allyl (6) derivatives completely inhibit implantation at doses 10, 3, 20, 20 and 30 mg/kg respectively.The 3,4-dichlorophenyl analogue (32) is effective at a dose of 30 mg/kg. 2-(3,5-Bistrifluoromethylphenyl)hydrazinothiazoline (51) and the corresponding dihydrothiazine (63) show a weaker activity.The biological profile of C 2696-Go has been investigated in detail.It appears to prevent implantation by its antiuterotropic activity and ability to inhibit desiduoma formation.